Senores Pharmaceuticals has informed that it enclosed copy of Newspaper Publication for extracts of Unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended December 31, 2025.
The above information is a part of company’s filings submitted to BSE.